Photo by nci from unsplash
Follicular lymphoma (FL) is the most frequent indolent B-cell lymphoma. The introduction of immunotherapy has greatly improved outcomes for FL patients, with a median overall survival (OS) now approaching 20… Click to show full abstract
Follicular lymphoma (FL) is the most frequent indolent B-cell lymphoma. The introduction of immunotherapy has greatly improved outcomes for FL patients, with a median overall survival (OS) now approaching 20 years. However, relapses are continuously seen during follow-up, and responses progressively shorten with each relapse, with a median survival after third-line therapy of 4.8 years.
Keywords:
follicular lymphoma;
relapse;
frontline treatment;
second relapse;
interval frontline
Journal Title: European Journal of Haematology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: European Journal of Haematology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!